• No results found

University of Groningen Mechanisms of TRAIL-resistance Zhang, Baojie

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Mechanisms of TRAIL-resistance Zhang, Baojie"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Mechanisms of TRAIL-resistance Zhang, Baojie

DOI:

10.33612/diss.124219664

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Zhang, B. (2020). Mechanisms of TRAIL-resistance: novel targets to enhance TRAIL sensitization for cancer therapy. University of Groningen. https://doi.org/10.33612/diss.124219664

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Mechanisms of TRAIL-Resistance

Novel Targets to Enhance TRAIL Sensitization for Cancer Therapy

(3)

The research presented in this PhD thesis was performed at the Department of Chemical and Pharmaceutical Biology, University of Groningen, the Netherlands.

Cover image: Designed by flo222 / pixabay Print: Ridderprint | www.ridderprint.nl. ISBN (printed version): 978-94-034-2657-0 ISBN (electronic version): 978-94-034-2656-3

(4)

Mechanisms of TRAIL-Resistance

Novel Targets to Enhance TRAIL Sensitization for Cancer Therapy

PhD thesis

to obtain the degree of PhD at the University of Groningen

on the authority of the

Rector Magnificus Prof. C. Wijmenga and in accordance with

the decision by the College of Deans. This thesis will be defended in public on

Monday 11 May 2020 at 9.00 hours

by

Baojie Zhang

born on 15 June 1986 in Shandong, China

(5)

Supervisors

Prof. W.J. Quax Prof. F.J. Dekker

Assessment Committee

Prof. K. Poelstra Prof. F.A.E. Kruyt Prof. G.J. Peters

(6)

Contents

Chapter 1

Introduction and scope of the thesis ... 7

Chapter 2 Death receptor 5 is activated by fucosylation in colon cancer cells ... 13

Chapter 3 Death Receptor 5 Displayed on Extracellular Vesicles Decreases TRAIL sensitivity of Colon Cancer Cells ... 39

Chapter 4 Improving TRAIL-induced apoptosis in cancers by interfering with histone modifications... 53

Chapter 5 Histone deacetylase inhibitors sensitize TRAIL-induced apoptosis in colon cancer cells ... 69

Chapter 6 A Novel Histone Acetyltransferase Inhibitor A485 Improves Sensitivity of Non-small-cell Lung Carcinoma Cells to TRAIL ... 95

Chapter 7 Summary and Future Perspectives ... 125

Chapter 8 Nederlandse Samenvatting ... 131

Bibliography ... 135

Acknowledgements ... 157

(7)

Referenties

GERELATEERDE DOCUMENTEN

This review showed that there are different contributions of TRAIL-R1 and TRAIL-R2 to TRAIL-mediated apoptosis which might be cell type specific.TRAIL-R1 induced apoptosis

marr i es Nora h and so the Vanstone sisters sha r e the Vanstone inheritance after all. The First Scene, Chap.. Lecount and Wragge use the other chaTactu rs as

qRT-PCR shows a clear decrease in expression of HDAC1, 2, 3 and 8 at mRNA level with knockdown levels in DLD-1 being better than in WiDr (Fig. Apoptotic cells induced by knockdown

Subsequently, we combined TRAIL with A485 on EGFR-TKI-sensitive and resistant NSCLC cells and showed that this combination synergistically improves cell death.. In

In this thesis, we unraveled molecular mechanisms controlling TRAIL sensitivity in tumor cells using DR4- and DR5- specific TRAIL variants (Chapter 2 and 3).. Moreover, we used

Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and

alterations in the sensitivity of DLD-1 cells to rhTRAIL WT and DHER after adding 2FF. DLD- 1 cells were firstly treated with 2FF for 3 or 5 days, followed by 24h incubation

Mechanisms of TRAIL-resistance: novel targets to enhance TRAIL sensitization for cancer therapy.. University